27/05/2026
🎗️ Understanding HER2-Positive Breast Cancer & Advanced Targeted Therapies
About 1 in 5 breast cancers are HER2-positive. While historically more aggressive, the past two decades have revolutionized treatment through HER2-targeted therapies that specifically block cancer growth while minimizing damage to healthy cells.
Depending on the stage of the disease, these advanced treatments are combined with conventional surgery or chemotherapy across three main categories:
🔹 Monoclonal Antibodies (e.g., Herceptin, Phesgo) – Block growth signals and trigger the immune system to destroy cancer cells.
🔹 Tyrosine Kinase Inhibitors (e.g., Nerlynx, Tukysa) – Oral medications that shut down the internal proteins instructing cells to grow.
🔹 Antibody-Drug Conjugates (e.g., Kadcyla, Enhertu) – "Smart" therapies that deliver potent chemotherapy directly inside the cancer cell.
From early-stage to metastatic breast cancer, treatment plans are highly personalized to the patient's specific health profile and dynamically adjusted to manage any side effects effectively.
Read more >>https://www.vejthani.com/health-article/her2-positive-breast-cancer-treatment/
For inquiries, or to make an appointment, inbox us or call our English hotline at +66 (0) 85-223-8888 or email service@vejthani.com
_____________________________________________________
👨⚕️Stay updated with the latest health trends through our social channels:
Line () : https://bit.ly/2SsDFgs
Youtube : http://bit.ly/2OpDlOv
IG : https://www.instagram.com/vejthani.hospital/
Twitter : https://twitter.com/Vejthani
Website : https://www.vejthani.com/
Make an Appointment : https://www.vejthani.com/make-an-appointment/
Talk to doctor: https://www.vejthani.com/talk-to-doctor/